Ana Cañuelo

Ana Cañuelo

Auto-generated profile, based on publicly available information

Ana Cañuelo

Departamento de Biología Experimental, Universidad de Jaén, Jaén, Spain

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2012 in Mechanisms of Ageing and Development
Verified
Journal Article
Closed access
ACAna Cañuelo
Ana Cañuelo
BGBienvenida Gilbert-López
Bienvenida Gilbert-López
PPPedro Pacheco-Liñán
Pedro Pacheco-Liñán
EMEsther Martínez-Lara
Esther Martínez-Lara
ESEva Siles
Eva Siles
AMAntonio Miranda-Vizuete
Antonio Miranda-Vizuete

8 February 2005 in Biochemical Journal
Verified
Journal Article
Open access
PDF file
JMJosé Antonio Muñoz-Gámez
José Antonio Muñoz-Gámez
DMDavid Martín-Oliva
David Martín-Oliva
RARocío Aguilar-Quesada
Rocío Aguilar-Quesada
ACAna Cañuelo
Ana Cañuelo
MNM. Isabel Nuñez
M. Isabel Nuñez
JOJavier Oliver
Javier Oliver
P53 deficiency confers resistance to doxo (doxorubicin), a clinically active and widely used antitumour anthracycline antibiotic. The purpose of the present study was to investigate the reversal mechanism of doxo resistance by the potent PARP [poly(ADP-ribose) polymerase] inhibitor ANI (4-amino-1,8-naphthalimide) in the p53-deficient breast cancer cell lines EVSA-T and MDA-MB-231. The effects of ANI, in comparison with doxo alone, on doxo-induced apoptosis, were investigated in matched pairs of EVSA-T or MDA-MB-231 with or without ANI co-treatment. Doxo elicited PARP activation as determined by Western blotting and immunofluorescence of poly(ADP-ribose), and ANI enhanced the cytotoxic activity of doxo 2.3 times and in a caspase-dependent manner. The long-term cytotoxic effect was studied by a colony-forming assay. Using this assay, ANI also significantly potentiates the long-term cytotoxic effect with respect to treatment with doxo alone. Decrease in mitochondrial potential together with an increase in cytochrome c release, association of Bax with the mitochondria and caspase 3 activation were also observed in the presence of ANI. Therefore PARP inhibition may represent a novel way of selectively targeting p53-deficient breast cancer cells. The underlying mechanism is probably a potentiation of unrepaired DNA damage, shifting from DNA repair to apoptosis due to the effective inhibition of PARP activity.

1 October 2019 in Neurobiology of Aging
Verified
Journal Article
Closed access
JGJesús Calahorra Garcia-Moreno
Jesús Calahorra Garcia-Moreno
MRMontserrat Porta de la Riva
Montserrat Porta de la Riva
EMEsther Martínez-Lara
Esther Martínez-Lara
ESEva Siles
Eva Siles
ACAna Cañuelo
Ana Cañuelo

14 September 2009 in Journal of Neurochemistry
Verified
Journal Article
Closed access
PDF file
RMRubén Martínez‐Romero
Rubén Martínez‐Romero
ACAna Cañuelo
Ana Cañuelo
EMEsther Martínez‐Lara
Esther Martínez‐Lara
FOFrancisco Javier Oliver
Francisco Javier Oliver
SCSara Cárdenas
Sara Cárdenas
ESEva Siles
Eva Siles

1 March 2012 in Journal of Applied Physiology
Verified
Journal Article
Closed access
PDF file
RMRubén Martínez-Romero
Rubén Martínez-Romero
ACAna Cañuelo
Ana Cañuelo
ESEva Siles
Eva Siles
FOF. Javier Oliver
F. Javier Oliver
EMEsther Martínez-Lara
Esther Martínez-Lara
The physiological response to hypobaric hypoxia represents a complex network of biochemical pathways in which the nitrergic system plays an important role. Previous studies have provided evidence for an interplay between the hypoxia-inducible factor-1 (HIF-1) and poly(ADP-ribose) polymerase-1 (PARP-1) under hypoxia. Here, we evaluate the potential involvement of nitric oxide (NO) in the cross talk between these two proteins. With this aim, we studied comparatively the effect of pharmacological inhibitors of NO production or PARP activity in the response of the mouse cerebral cortex to 4 h of exposure to a simulated altitude of 31,000 ft. Particularly, we analyzed the NO and reactive oxygen species production, the expression of NO synthase (NOS) isoforms, PARP-1 activity, HIF-1α expression and HIF-1 transcriptional activity, the protein level of the factor inhibiting HIF, and, finally, beclin-1 and fractin expression, as markers of cellular damage. Our results demonstrate that the reduction of NO level did not affect reactive oxygen species production but significantly 1) dampened the posthypoxic increase in neuronal NOS and inducible NOS expression without altering endothelial NOS protein level; 2) prevented PARP activation; 3) decreased HIF-1α response to hypoxia; 4) achieved a higher long-term HIF-1 transcriptional activity by reducing factor inhibiting HIF expression; and 5) reduced hypoxic damage. The pharmacological inhibition of PARP reproduced the NOS expression pattern and the HIF-1α response observed in NOS-inhibited mice, supporting its involvement in the NO-dependent regulation of hypoxia. As a whole, these results provide new data about the molecular mechanism underlying the beneficial effects of controlling NO production under hypobaric hypoxic conditions.

10 November 2015 in Food & Function
Verified
Journal Article
Closed access
PDF file
EMEsther Martínez-Lara
Esther Martínez-Lara
APAna Peña
Ana Peña
JCJesús Calahorra
Jesús Calahorra
ACAna Cañuelo
Ana Cañuelo
ESEva Siles
Eva Siles
A proposed model of action of HT-treatment in the hypoxic response of sublethally damaged renal cells is presented.